Dr.Finance (WAR:DRF) Current Accrued Expense: zł0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:DRF Dr.Finance SA WAR:DRF
36 GF Score
Price zł1.57
GF Value zł0.40
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Dr.Finance Current Accrued Expense?

Dr.Finance WAR:DRF -0.94% 36 Current Accrued Expense is zł0.00 Mil as of Jun. 2026. GuruFocus rates WAR:DRF with a GF Score™ of 36/100 and a GF Value™ of zł0.40 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Dr.Finance's Current Accrued Expense for the quarter that ended in Jun. 2026 was zł0.00 Mil.

Dr.Finance Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Dr.Finance's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr.Finance Current Accrued Expense Chart

Dr.Finance Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Dr.Finance Semi-Annual Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:DRF
36GF Score
Dr.Finance SA WAR:DRF
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr.Finance Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of zł0.00 Mil mean?
Dr.Finance (WAR:DRF) has a Current Accrued Expense of zł0.00 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Dr.Finance and its competitors.
Is Dr.Finance's Current Accrued Expense too high?
Dr.Finance's current Current Accrued Expense is zł0.00 Mil. Overall, Dr.Finance has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dr.Finance's Current Accrued Expense compare to V and MA?
Dr.Finance's Current Accrued Expense of zł0.00 Mil can be compared against companies in the Credit Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Credit Services company?
A good Current Accrued Expense depends on the Credit Services industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Dr.Finance and its competitors. Dr.Finance's current Current Accrued Expense is zł0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr.Finance stock overvalued right now?
Based on GuruFocus' analysis, Dr.Finance (WAR:DRF) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.40, compared to a current price of zł1.57 — trading 292.5% above its estimated fair value. The current Current Accrued Expense is zł0.00 Mil. Dr.Finance's overall GF Score™ is 36/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Dr.Finance (WAR:DRF), the current Current Accrued Expense is zł0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr.Finance (WAR:DRF) Overvalued in 2026?

Based on GuruFocus' analysis, Dr.Finance stock appears to be overvalued. The current stock price of zł1.57 is trading 292.5% above its estimated GF Value™ of zł0.40. GuruFocus considers Dr.Finance to be Significantly Overvalued.

Key valuation signals for WAR:DRF:

  • Current Accrued Expense: zł0.00 Mil
  • GF Value™: zł0.40 vs. price of zł1.57 (292.5% above fair value)
  • GF Score™: 36/100 with 6 warning signs

No single metric tells the full story. See the WAR:DRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dr.Finance Business Description

Address ul. Braniborska 65/12, Wroclaw, POL, 53-680
Dr.Finance SA is a Polish financial intermediary that distributes loans and other financial products to consumers and small businesses. The company operates through a network of branches and agents across Poland, connecting clients with banks and other lenders rather than lending from its own balance sheet. Its product range covers working capital loans, investment loans, leasing, and factoring, along with related financial services. Revenue is generated primarily through commissions and fees paid by partner financial institutions for intermediation and distribution services, supplemented by fees charged to clients for advisory and application support. The company targets individual borrowers, entrepreneurs, and small and medium-sized enterprises seeking financing that may not be readily available directly from banks. Its activities are concentrated in the Polish market, where it competes with other loan brokers and multi-agency distribution networks.
36GF Score

Get the complete analysis for WAR:DRF

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł1.57
Price
zł0.40
GF Value